Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)

Clinical trial NCT00143975 · COMPLETED

Trial details

NCT number: NCT00143975
Sponsor: University of Ulm
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2004-06-01
Primary completion: 2007-07-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.